Cargando…
Clinical impact of extensive molecular profiling in advanced cancer patients
Previous precision medicine studies have investigated conventional molecular techniques and/or limited sets of gene alterations. The aim of this study was to describe the impact of the next-generation sequencing of the largest panel of genes used to date in tumour tissue and blood in the context of...
Autores principales: | Cousin, Sophie, Grellety, Thomas, Toulmonde, Maud, Auzanneau, Céline, Khalifa, Emmanuel, Laizet, Yec’han, Tran, Kevin, Le Moulec, Sylvestre, Floquet, Anne, Garbay, Delphine, Robert, Jacques, Hostein, Isabelle, Soubeyran, Isabelle, Italiano, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299780/ https://www.ncbi.nlm.nih.gov/pubmed/28179005 http://dx.doi.org/10.1186/s13045-017-0411-5 |
Ejemplares similares
-
Targeting ERBB2 mutations in solid tumors: biological and clinical implications
por: Cousin, Sophie, et al.
Publicado: (2018) -
Inactivating mutations in genes encoding for components of the BAF/PBAF complex and immune-checkpoint inhibitor outcome
por: Courtet, Kevin, et al.
Publicado: (2020) -
Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas
por: Blanchi, Julie, et al.
Publicado: (2023) -
Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas
por: Crombé, Amandine, et al.
Publicado: (2022) -
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
por: Italiano, Antoine, et al.
Publicado: (2021)